FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes

被引:46
作者
Alanko, T
Rosenberg, M
Saksela, O
机构
[1] Univ Helsinki, Dept Virol, Haartman Inst, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Dermatol, Helsinki, Finland
关键词
D O I
10.1046/j.1523-1747.1999.00636.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Melanocytes, the pigment forming cells of the skin, form an almost nonproliferating cell population located to the lowermost part of the epidermis, Normally melanocytes are not found higher in the epidermis or in the dermis. Nevi consist of melanocytes with altered growth characteristics and localization. The common pigmented nevus, a benign skin lesion, develops when melanocytes proliferate in the dermo-epidermal junction or in the dermis. Here we report growth characteristics of in vitro cultured normal human melanocytes and dermal nevus-derived melanocytes. As previously reported, nevus cells have a moderate to high FGF-2 expression level. Here we demonstrate that dermal nevus cells are able to survive in three-dimensional type 1 collagen culture, while normal human melanocytes rapidly undergo apoptosis, Melanocytes also, however, survive in collagen cultures in the presence of exogenous FGF-2, The survival of nevus cells in collagen is suppressed by protamine, an inhibitor of FGF-mediated cell stimulation. The in vivo growth environment of dermal nevus cells consists largely of type I and type III collagens. The results suggest that FGF-2 expression by nevus cells allows them to adapt to grow in the dermis. FGF-2 obviously has importance as a melanocyte survival factor and probably also in the development of malignant melanoma.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 44 条
[1]   FGF-2 inhibits apoptosis in human teratocarcinoma cells during differentiation on collagen substratum [J].
Alanko, T ;
Tienari, J ;
Lehtonen, E ;
Saksela, O .
EXPERIMENTAL CELL RESEARCH, 1996, 228 (02) :306-312
[2]   Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA [J].
Aviezer, D ;
Iozzo, RV ;
Noonan, DM ;
Yayon, A .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :1938-1946
[3]  
BAIRD A, 1991, CANCER CELL-MON REV, V3, P239
[4]   The immunohistochemical identification of human oral mucosal melanocytes [J].
Barrett, AW ;
Raja, AMH .
ARCHIVES OF ORAL BIOLOGY, 1997, 42 (01) :77-81
[5]   Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells [J].
Bono, F ;
Rigon, P ;
Lamarche, I ;
Savi, P ;
Salel, V ;
Herbert, JM .
BIOCHEMICAL JOURNAL, 1997, 326 :661-668
[6]   USE OF AN AQUEOUS SOLUBLE TETRAZOLIUM FORMAZAN ASSAY FOR CELL-GROWTH ASSAYS IN CULTURE [J].
CORY, AH ;
OWEN, TC ;
BARLTROP, JA ;
CORY, JG .
CANCER COMMUNICATIONS, 1991, 3 (07) :207-212
[7]   CLONING AND EXPRESSION OF 2 DISTINCT HIGH-AFFINITY RECEPTORS CROSS-REACTING WITH ACIDIC AND BASIC FIBROBLAST GROWTH-FACTORS [J].
DIONNE, CA ;
CRUMLEY, G ;
BELLOT, F ;
KAPLOW, JM ;
SEARFOSS, G ;
RUTA, M ;
BURGESS, WH ;
JAYE, M ;
SCHLESSINGER, J .
EMBO JOURNAL, 1990, 9 (09) :2685-2692
[8]   TRANSFORMATION OF MURINE MELANOCYTES BY BASIC FIBROBLAST GROWTH-FACTOR CDNA AND ONCOGENES AND SELECTIVE SUPPRESSION OF THE TRANSFORMED PHENOTYPE IN A RECONSTITUTED CUTANEOUS ENVIRONMENT [J].
DOTTO, GP ;
MOELLMANN, G ;
GHOSH, S ;
EDWARDS, M ;
HALABAN, R .
JOURNAL OF CELL BIOLOGY, 1989, 109 (06) :3115-3128
[9]   GENETIC SUSCEPTIBILITY TO NEVI - A TWIN STUDY [J].
EASTON, DF ;
COX, GM ;
MACDONALD, AM ;
PONDER, BAJ .
BRITISH JOURNAL OF CANCER, 1991, 64 (06) :1164-1167
[10]   HISTOGENESIS OF RECURRENT NEVUS [J].
ESTRADA, JA ;
PIERARDFRANCHIMONT, C ;
PIERARD, GE .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1990, 12 (04) :370-372